Renaissance Technologies
CO

Renaissance Technologies’s Global Cord Blood Corporation CO Stock Holding History

Renaissance Technologies’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,348,549
Closed -$702K – 4459
2023
Q1 		$702K Hold
2,348,549
– – ﹤0.01% 2693
2022
Q4 		$702K Hold
2,348,549
– – ﹤0.01% 2736
2022
Q3 		$7.02M Sell
2,348,549
-197,434
-8% -$485K 0.01% 1229
2022
Q2 		$7.54M Sell
2,545,983
-143,991
-5% -$446K 0.01% 1276
2022
Q1 		$10.4M Sell
2,689,974
-198,215
-7% -$823K 0.01% 1106
2021
Q4 		$12.1M Sell
2,888,189
-177,321
-6% -$753K 0.02% 973
2021
Q3 		$14.3M Sell
3,065,510
-296,464
-9% -$1.45M 0.02% 838
2021
Q2 		$18M Sell
3,361,974
-209,000
-6% -$1.09M 0.02% 816
2021
Q1 		$16.2M Sell
3,570,974
-340,100
-9% -$1.48M 0.02% 904
2020
Q4 		$14.5M Sell
3,911,074
-86,578
-2% -$332K 0.02% 928
2020
Q3 		$14.2M Buy
3,997,652
+180,590
+5% +$626K 0.01% 926
2020
Q2 		$11.8M Buy
3,817,062
+576,864
+18% +$1.68M 0.01% 1125
2020
Q1 		$10.3M Buy
3,240,198
+125,861
+4% +$550K 0.01% 1143
2019
Q4 		$15.6M Buy
3,114,337
+98,332
+3% +$470K 0.01% 1154
2019
Q3 		$14.6M Buy
3,016,005
+189,109
+7% +$992K 0.01% 1149
2019
Q2 		$16.3M Buy
2,826,896
+29,396
+1% +$194K 0.01% 1087
2019
Q1 		$19.6M Buy
2,797,500
+212,100
+8% +$1.4M 0.02% 979
2018
Q4 		$16.7M Sell
2,585,400
-26,600
-1% -$170K 0.02% 995
2018
Q3 		$18.3M Buy
2,612,000
+331,600
+15% +$2.49M 0.02% 996
2018
Q2 		$21.6M Sell
2,280,400
-3,500
-0.2% -$33.5K 0.02% 876
2018
Q1 		$23.3M Buy
2,283,900
+357,400
+19% +$3.65M 0.03% 852
2017
Q4 		$19.2M Buy
1,926,500
+320,200
+20% +$3.5M 0.02% 965
2017
Q3 		$17.9M Buy
1,606,300
+455,200
+40% +$5.33M 0.02% 969
2017
Q2 		$10.9M Buy
1,151,100
+291,600
+34% +$2.33M 0.01% 1232
2017
Q1 		$5.72M Buy
859,500
+52,700
+7% +$312K 0.01% 1594
2016
Q4 		$4.94M Sell
806,800
-27,800
-3% -$138K 0.01% 1679
2016
Q3 		$4.26M Buy
834,600
+85,600
+11% +$456K 0.01% 1705
2016
Q2 		$4.31M Buy
749,000
+27,100
+4% +$165K 0.01% 1693
2016
Q1 		$4.38M Buy
721,900
+59,045
+9% +$353K 0.01% 1728
2015
Q4 		$4.22M Buy
662,855
+98,855
+18% +$624K 0.01% 1614
2015
Q3 		$3.4M Buy
564,000
+62,100
+12% +$386K 0.01% 1651
2015
Q2 		$3.09M Buy
501,900
+197,300
+65% +$1.21M 0.01% 1767
2015
Q1 		$1.56M Buy
304,600
+122,900
+68% +$605K ﹤0.01% 2067
2014
Q4 		$821K Buy
181,700
+11,500
+7% +$54.6K ﹤0.01% 2222
2014
Q3 		$832K Buy
170,200
+38,400
+29% +$186K ﹤0.01% 2113
2014
Q2 		$728K Sell
131,800
-2,700
-2% -$12.1K ﹤0.01% 2172
2014
Q1 		$538K Sell
134,500
-30,700
-19% -$125K ﹤0.01% 2332
2013
Q4 		$662K Sell
165,200
-120,400
-42% -$479K ﹤0.01% 2263
2013
Q3 		$1.08M Sell
285,600
-47,700
-14% -$179K ﹤0.01% 1973
2013
Q2 		$937K Buy
+333,300
New +$951K ﹤0.01% 1961

Other funds holding CO

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
OA
Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Renaissance Technologies's CO Position: Q2 2023 in Review

Renaissance Technologies sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 2,348,549 shares — an estimated $702K sold.

Renaissance Technologies first reported a position in CO in Q2 2013 and held it in 40 quarters. The position peaked at $23.3M in Q1 2018. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Renaissance Technologies reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 2,348,549 Global Cord Blood Corporation shares in Q2 2023, an estimated $702K.
  • Renaissance Technologies first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 40 quarters.
  • Renaissance Technologies's Global Cord Blood Corporation position peaked at $23.3M in Q1 2018.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.